Sort
261,768 grants matching “gene therapy”
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer
$1,071,751Loren D Walensky · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,071,699Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
PIWI proteins and PIWI-interacting small RNAs guard the genomic integrity of germ cells
$1,071,691Astrid Haase · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Sphingolipids in Cancer Therapy and Angiogenesis
$1,071,665Yusuf Awni Hannun · Medical University Of South Carolina · P01 · FY2007 · CA
Factors Influencing Genetic Transcription Initiation And Termination
$1,071,631Robert J Crouch · Child Health And Human Development · Z01 · FY2007 · HD
PREVENT PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKER ENDPOINTS TASK ORDER: USE OF CARNOSIC ACID AND VIVOX40 FOR BREAST CANCER PREVENTION
$1,071,582Alex Lyubimov · University Of Illinois At Chicago · N01 · FY2020 · CA
Cancer-cell specific therapy: photo-immunotherapy
$1,071,513Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,071,429Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
The Phenomenology And Neurophysiology Of Juvenile Bipolar Disorder
$1,071,405Ellen Leibenluft · National Institute Of Mental Health · ZIA · FY2014 · MH
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,071,276Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2017 · CA
Coordinating center for the NCI small cell lung cancer research consortium
$1,071,245Charles M Rudin · Sloan-Kettering Inst Can Research · U24 · FY2021 · CA
HDAC/PI3K Dual Inhibitors for Treatment of Rare Cancers
$1,071,030Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
BMP Inhibitors to Treat Fibrodysplasia Ossificans Progressiva
$1,071,030Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Novel Treatment for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
$1,071,030Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$1,071,030Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Development of Malaria Transmission-Blocking Drugs
$1,071,030Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Laboratory of Oral Connective Tissue Biology
$1,071,000Martha Somerman · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR
Gene Therapy for Urea Cycle Disorders
$1,070,903James M Wilson · University Of Pennsylvania · P01 · FY2014 · HD
Molecular prostheses for mitochondrial disorders
$1,070,899Vamsi Krishna Mootha · Massachusetts General Hospital · R01 · FY2012 · GM
Novel bisphosphonates for prostate cancer therapy
$1,070,889Alexander Karpeisky · Mbc Pharma, Inc. · R44 · FY2011 · CA
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic
$1,070,823Lynn C. Hartmann · Mayo Clinic Rochester · K12 · FY2009 · CA
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
$1,070,801Ellen L. Goode · Mayo Clinic Rochester · R01 · FY2021 · CA
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
$1,070,697Tracy Fischer · Temple Univ Of The Commonwealth · P01 · FY2017 · MH
Cell-membrane permeant proteins to directly generate human and mouse iPS cells
$1,070,652Neal David Epstein · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Multiscale Mathematical Modeling of Cancer Progression
$1,070,597Vito Quaranta · Vanderbilt University · U54 · FY2012 · CA